BTMD · biote Corp. · Documents

May 10

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $46.8M ▲ 4.4% Net loss $2.07M Diluted EPS -$0.06

May 7

Earnings call

Q1 2024 earnings call

May 7

Current report 8-K

Financial results

Apr 29

Current report 8-K Events of Apr 23

Entered into a material agreement, Regulation FD disclosure

Apr 11

Proxy statement DEF 14A Meeting May 21, 2024

Proxy statement

Apr 11

Annual report to holders ARS

Annual report to holders

Apr 11

Proxy statement DEFA14A

Proxy statement

Mar 15

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $185.36M ▲ 12.4% Net income $3.32M Diluted EPS $0.13

Mar 14

Current report 8-K

Regulation FD disclosure

Mar 12

Earnings call

Q4 2023 earnings call

Mar 12

Current report 8-K

Financial results

Feb 20

Current report 8-K Events of Feb 13

Entered into a material agreement, Regulation FD disclosure

Jan 25

Current report 8-K

Other events

Jan 17

Current report 8-K

Financial results, Regulation FD disclosure

Jan 11

Current report 8-K Events of Jan 8

Director or officer change, or executive pay, Regulation FD disclosure

Nov 13

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $45.56M ▲ 8.5% Net income $7.53M ▲ 50100.0% Diluted EPS $0.24

Nov 7

Earnings call

Q3 2023 earnings call

Nov 7

Current report 8-K

Financial results

Aug 11

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $49.26M ▲ 19.1% Net loss $5.14M Diluted EPS -$0.25

Aug 10

Earnings call

Q2 2023 earnings call

Aug 10

Current report 8-K

Financial results

Jun 9

Current report 8-K Events of Jun 8

Entered into a material agreement, Change to shareholders' rights, Shareholder vote results, Other events

Jun 9

Tender offer SC TO-I/A

Tender offer

Jun 7

Current report 8-K Events of Jun 5

Other events

May 23

Registration statement S-4/A

Registration statement

May 19

Current report 8-K Events of May 17

Shareholder vote results

May 16

Registration statement S-4/A

Registration statement

May 12

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $44.84M ▲ 20.7% Net loss $6.81M Diluted EPS -$0.39

May 9

Current report 8-K

Financial results, Other events

May 9

Tender offer SC TO-I

Tender offer

May 9

Registration statement S-4

Registration statement

Apr 14

Proxy statement DEF 14A Meeting May 17, 2023

Proxy statement

Apr 14

Annual report to holders ARS

Annual report to holders

Mar 29

Quarterly report 10-Q/A FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $41.36M ▲ 19.0% Net loss $2.61M Diluted EPS -$0.34

Mar 29

Quarterly report 10-Q/A FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $41.97M ▲ 18.0% Net income $15K Diluted EPS $0.00

Mar 29

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $164.96M ▲ 18.3% Net loss $969K Diluted EPS -$0.12

Mar 28

Current report 8-K

Financial results

Mar 24

Current report 8-K

Earlier financial statements no longer reliable

Feb 22

Current report 8-K Events of Feb 15

Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change

Jan 3

Registration statement S-1/A

Registration statement

Dec 12

Registration statement S-1

Registration statement

Nov 14

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $41.97M ▲ 18.0% Net loss $13.24M Diluted EPS -$1.74

Nov 8

Current report 8-K

Financial results

Nov 7

Current report 8-K Events of Nov 3

Director or officer change, or executive pay, Regulation FD disclosure

Oct 11

Current report 8-K Events of Oct 10

Regulation FD disclosure

Aug 25

Current report 8-K

Regulation FD disclosure

Aug 24

Current report 8-K

Director or officer change, or executive pay, Regulation FD disclosure

Aug 15

Current report 8-K/A Events of Aug 9

Financial results

Aug 15

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $41.36M ▲ 19.0% Net income $115.46M Diluted EPS $2.01

Aug 10

Current report 8-K Events of Jul 20

Financial results